The U.S. Drug Enforcement Administration has recently announced that it
will consider rescheduling Marijuana from a Schedule I drug to a Schedule
II drug. As it is currently scheduled, it has no acceptable medical use
and a high potential for abuse. In fact, it is currently scheduled with
drugs such as heroin and LSD. If it were to be rescheduled to a Schedule
II drug, it would be classified with other drugs such as Oxycodone and
Adderall which have an acceptable medical purpose. As such, researchers
would be able to study Marijuana in more depth, even to the point of doing
clinical trials on humans. This could lead to the development of canaboid-based
medicines. As of today, the government has an exclusive contract with
the University of Mississippi for the cultivation of Marijuana for medical
research. With the rescheduling, more places could potentially be authorized
to cultivate marijuana for federally funded research. The DEA has stated
that a formal decision will be announced around July of 2016.
At the Law Offices of Paul Petruzzi, we fully support the rescheduling
of Marijuana. Marijuana has proven time and time again to help those with
certain illnesses. To leave Marijuana as a Schedule I drug would undermine
the development and research of all the potential benefits of Marijuana.
The rescheduling of Marijuana is a step in the right direction for our
country as a whole.
Read about it